Skip to content
Disclosery

Pershing Edward

Reporting owner on Forms 3, 4 and 5, CIK 1689739.

Pershing Edward reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-05.

Issuers

IssuerRoles in the latest filingFilingsLast filed
PROVECTUS BIOPHARMACEUTICALS, INC. CIK 315545director, officer (CEO), 10% owner12026-10-05

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
PROVECTUS BIOPHARMACEUTICAL… 8% Unsecured Convertible Promissory Note, derivative2026-10-03M exercised-$0Form 4
PROVECTUS BIOPHARMACEUTICAL… Series D-1 Convertible Preferred Stock, derivative2026-10-03M exercised+13,216$02,975,925Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001493152-26-045713 PROVECTUS BIOPHARMACEUTICALS, INC.2026-10-05